Skip to content
Neuro-ophthalmology

Slit Ventricle Syndrome

Slit ventricle syndrome (SVS) is a complication that occurs after VP shunt (ventriculoperitoneal shunt) surgery. It refers to a condition in which the ventricles become slit-like on neuroimaging and the patient presents with symptoms related to CSF shunting.

In 1982, Rekate et al. defined “SVS”. Its triad was headache lasting 10–90 minutes, slit-like ventricles on imaging, and slow refilling of the valve 2). The term “overdrainage” itself was first used by Becker et al. in 1968 1).

Epidemiology is as follows:

  • SVS occurs in 3–5% of VP shunt patients
  • Symptoms appear 2–5 years after shunt placement, and the average time from hydrocephalus diagnosis to SVS onset is 4.3 years
  • Peak onset is at 4–6 years of age
  • Slit-like ventricles on imaging are seen in 10–85% of shunt patients, but only a subset have symptomatic SVS 1)
  • The exact frequency of overdrainage varies widely from 2% to 71%, which is due to inconsistencies in diagnostic criteria 1)

Main risk factors are as follows:

  • Small head circumference below the 25th percentile
  • Shunt placement in infancy (younger age increases risk)
  • Complication of secondary craniosynostosis
  • Cause of hydrocephalus (aqueductal stenosis, intraventricular hemorrhage, brain infection, communicating hydrocephalus, etc.)

SVS can also occur after VP shunt placement in adults.

Q Which patients are more likely to develop slit ventricle syndrome?
A

It occurs in 3–5% of VP shunt patients, most commonly 2–5 years after shunt placement and at ages 4–6 years. Small head circumference (below the 25th percentile) and shunt placement in infancy are known risk factors.

The typical subjective symptom of SVS is episodic headache, with postural headache being characteristic1).

Two patterns of headache are distinguished as follows.

  • Low ICP-related headache: Worsens when standing up and improves when lying down. Shows characteristics similar to post-lumbar puncture headache.
  • High ICP-related headache: Worsens when lying down, tends to occur in the morning and persist throughout the day.

The typical duration of headache is 10–15 minutes, often accompanied by nausea, vomiting, and hyperventilation. Changes in consciousness may also occur. Asymptomatic cases exist.

In children, the impact on daily life is significant, including limitations in social activities, school absenteeism, and decline in academic performance1).

Clinical findings (findings confirmed by physician examination)

Section titled “Clinical findings (findings confirmed by physician examination)”

Systemic findings include the following.

  • Changes in vital signs (bradycardia, hypertension)
  • Complications: subdural hematoma, intracerebral hemorrhage, hypotension, inversion of the cerebral cortex
  • Weakness, ataxia, seizures, cranial nerve disorders1)

Ophthalmic findings are an important group of findings in this disease.

  • Papilledema: a major ophthalmic sign of shunt failure. However, sensitivity is not high.
  • Optic atrophy and pale optic disc: Occurs after chronic intracranial hypertension. Once optic atrophy develops, the disc can no longer swell, and papilledema may not be apparent even when ICP is elevated → Shunt failure cannot be ruled out even if the disc is flat.
  • Visual impairment: Decreased visual acuity, color vision abnormalities, visual field defects.
  • Ocular motility abnormalities: Intermittent horizontal diplopia, non-localizing abducens nerve palsy (under high ICP settings).
  • Pupillary abnormalities
  • Cortical blindness
  • Dorsal midbrain syndrome (Parinaud syndrome): Occurs due to increased ICP at the level of the cerebral aqueduct.

There have been reports of cases where SVS presented only with visual symptoms. Because systemic symptoms are absent and imaging shows no ventricular enlargement, ocular findings are easily overlooked. Delayed diagnosis carries a risk of permanent vision loss.

Q Can slit ventricle syndrome be detected with only eye symptoms?
A

Yes. Cases presenting only with visual symptoms have been reported. Since systemic symptoms are absent and imaging shows no ventricular enlargement, ocular findings may be the only clue. If overlooked, there is a risk of permanent vision loss.

The main cause of SVS is the loss of ventricular compliance due to repeated cycles of ventricular expansion and decompression from a VP shunt.

Three pathophysiological hypotheses have been proposed.

Over-drainage theory

CSF over-drainage: The ventricles collapse, causing intermittent obstruction of the proximal catheter.

Shunt obstruction/cerebral hypotension: Repeated cycles of increased ICP during obstruction and rapid drainage when open.

Gliosis theory

Reactive gliosis: Chronic CSF drainage leads to formation of gliotic scar tissue in the subependymal layer.

Proximal obstruction: Scar tissue prevents ventricular expansion, fixing the ventricular collapse 2).

Craniocerebral Disproportion Theory

Craniocerebral disproportion: Early VP shunt drainage and overlapping sutures cause brain growth to become disproportionate to cranial volume.

Complication of premature suture fusion: Leads to microcephaly and dolichocephaly disproportion.

From the perspective of Laplace’s law (T = P × R), when the ventricle collapses (small R), higher pressure (P) is needed for expansion. This can result in both overdrainage and underdrainage.

Venous stasis and increased brain elasticity theory has also been proposed. Shunt-induced cerebral hypotension leads to venous dilation, and when ICP rises, venous collapse occurs → the brain becomes rigid, increasing vulnerability to pressure changes2).

In SVS, ventricular enlargement is not observed, so the inability to rule out shunt failure based solely on imaging findings is the major diagnostic pitfall.

The following tests are combined for evaluation.

TestPurposeNotes
Brain CTConfirmation of slit-like ventriclesSVS cannot be ruled out even without ventricular enlargement
Shunt series (X-ray)Confirmation of shunt pathwayEvaluation of catheter fracture or malposition
MRIAnatomical evaluation of ventricles and cisternsMore detailed than CT. Note that SVS may show no ventricular enlargement
Lumbar punctureAssessment of intracranial pressureICP value directly determines treatment strategy
Technetium scanFunctional assessment of CSF flow pathwaysUseful for identifying obstruction sites

ICP monitoring is an important test that forms the basis of Rekate’s type 5 classification (determination of management strategy based on ICP values)1).

Indirect imaging findings (suggesting overdrainage) include the following1).

  • Small posterior cranial fossa
  • Skull thickening
  • Dolichocephaly
  • Suture sclerosis near the skull base
  • Parenchymal calcification
  • Hyperpneumatization of the paranasal sinuses

Differential diagnosis requires excluding other causes of headache, including migraine 1). Note that in the presence of optic atrophy, papilledema does not occur, so a normal fundus finding does not rule out shunt failure.

Q Can shunt failure occur even if CT shows normal ventricles?
A

Yes. In SVS, ventricular enlargement is not seen, so normal ventricular size on CT does not rule out shunt failure. Comprehensive evaluation including position-dependent headache, ophthalmological findings, and valve refill rate is necessary.

The treatment goal is resolution of headache, not normalization of ventricular size on imaging 1). Once SVS is established, normalization of ventricular size cannot be expected, so this point should guide treatment decisions.

  • Adjustment of programmable valve pressure setting: Increase the opening pressure in cases of overdrainage. Incremental titration, one step at a time, is recommended 1). Reports indicate that valve pressure increase alone can avoid or delay surgery in about one-third of cases 1).
  • Antimigraine drugs: Used when shunt function is normal and there is subacute or chronic headache. Options include cyproheptadine and beta-blockers (stabilization of intracranial vessels, suppression of vasodilation).
  • Corticosteroids: Used to lower ICP during symptomatic SVS episodes.
  • Acetazolamide: Used as a temporary measure to suppress CSF production.
  • Mannitol: Used to relieve acute headache2).
  • VP shunt replacement or revision: Performed when shunt malfunction occurs.
  • Addition of an antisiphon device (ASD): Prevents excessive CSF drainage due to gravity when standing. Combined use of a programmable ASD and programmable valve is recommended 1)
  • Endoscopic third ventriculostomy (ETV): Considered for non-communicating hydrocephalus, shunt obstruction, and SVS. This procedure creates a small opening in the floor of the third ventricle, with a reported success rate of 82.7%. In cases with slit-like ventricles and overdrainage, ventricular enlargement should be considered before ETV
  • External ventricular drainage (EVD): Used as a transitional bridging strategy when raising shunt pressure 2)
  • Subtemporal decompression: A traditional management method but with a high recurrence rate

Treatment algorithm (Panagopoulos et al., 2024)

Section titled “Treatment algorithm (Panagopoulos et al., 2024)”

Panagopoulos et al. proposed the following stepwise algorithm 1).

StepContent
1Exclude non-shunt-related causes of headache
2Headache consistent with overdrainage → Increase valve opening pressure
3Insufficient effect + ASD not placed → Insert ASD inline into valve mechanism
4Increase ASD pressure (if adjustable) or replace with high-opening-pressure ASD
5Replace with programmable ASD + programmable valve and adjust both

It is recommended to use a programmable valve in combination with an antisiphon device from the initial shunt placement1).

Q Will symptoms improve if shunt pressure is increased?
A

Increasing valve pressure avoided or delayed surgery in about one-third of cases. However, symptoms may temporarily worsen during the transition, so stepwise adjustment one step at a time is important. If the effect is insufficient, consider adding an antisiphon device.

6. Pathophysiology and Detailed Mechanisms

Section titled “6. Pathophysiology and Detailed Mechanisms”

The core pathophysiology of SVS is decreased brain compliance, with the pressure/volume curve shifted to the left 1).

Laplace’s law and the vicious cycle of ventricular collapse

Section titled “Laplace’s law and the vicious cycle of ventricular collapse”

From the relationship T = P × R (T: wall tension, P: transmural pressure, R: ventricular radius), when R decreases due to ventricular collapse, a higher transmural pressure (P) is required to expand the ventricle. If ventricular wall compliance is lost through repeated VP shunt cycles, this vicious cycle becomes fixed.

Rekate classified SVS into 5 types based on ICP waveforms recorded during monitoring 1, 2). In typical SVS (type 2), chronic overdrainage causes ventricular wall collapse, leading to intermittent obstruction of the proximal catheter. After a severe headache attack, slight ventricular enlargement reopens the catheter hole, repeating the cycle.

Stiff ventricle (ventricular wall stiffening)

Section titled “Stiff ventricle (ventricular wall stiffening)”

Chronic CSF drainage leads to the formation of gliotic scar tissue, which inhibits ventricular expansion. This is considered the mechanism of slit-like ventricle fixation in SVS 2).

Venous stasis and increased brain elasticity

Section titled “Venous stasis and increased brain elasticity”

Shunt-induced intracranial hypotension causes venous dilation, and venous collapse occurs when ICP rises. The brain becomes incompressible and rigid, leading to a sharp increase in ICP even with minor volume changes 2).


7. Latest research and future perspectives (reports at research stage)

Section titled “7. Latest research and future perspectives (reports at research stage)”

Panagopoulos et al. (2024) reported that telemetric ICP measurement systems are gaining attention as a technology linking clinical parameters of SVS with decreased brain compliance 1). Dynamic ICP monitoring may enable detailed evaluation of shunt function, which was previously difficult to assess.

Yoon et al. (2021) reported a case of SVS in a 15-year-old female (with a STRATA adjustable valve for 15 years for communicating hydrocephalus) 2). When raising the shunt pressure from 2.0 to 2.5, symptom exacerbation occurred during the transition, so an EVD was inserted into the left lateral ventricle (opening pressure 22 mmHg). CT on day 3 showed slight enlargement of the right lateral ventricle and resolution of headache. The EVD was removed after 5 days, and the patient remained asymptomatic at 15 months. This case demonstrates the usefulness of a bridge strategy combining neuronavigation-assisted EVD insertion into slit-like ventricles with gradual pressure adjustment.

Standardization of Diagnostic Criteria and Future Challenges

Section titled “Standardization of Diagnostic Criteria and Future Challenges”

Panagopoulos et al. (2024) pointed out that there is no widely accepted diagnostic definition for SVS, and this inconsistency affects the reliability of epidemiological data 1). Establishing an international consensus is a future challenge. Additionally, next-generation devices combining programmable ASD and programmable valves are enabling stepwise modification of both ICP and drainage mode. Further research is needed on age-related differences in ICP reference values and CSF pressure/volume regulation between children and adults.


  1. Panagopoulos D, Gavra M, Boviatsis E, Korfias S, Themistocleous M. Chronic Pediatric Headache as a Manifestation of Shunt Over-Drainage and Slit Ventricle Syndrome in Patients Harboring a Cerebrospinal Fluid Diversion System: A Narrative Literature Review. Children. 2024;11(5):596.

  2. Yoon SY, Kim SK, Phi JH. Bridging the intracranial pressure gap: a smooth transition strategy for slit ventricle syndrome. J Surg Case Rep. 2021;2021(7):rjab290.

  3. Panagopoulos D, Karydakis P, Themistocleous M. Slit ventricle syndrome: Historical considerations, diagnosis, pathophysiology, and treatment review. Brain Circ. 2021;7(3):167-177. PMID: 34667900.

Copy the article text and paste it into your preferred AI assistant.